المؤلفون: Chloe Baker, Emma Hall, Daniel Nava Rodrigues, Claudia Bertan, Susana Miranda, Nuria Porta, Ruth Riisnaes, Mateus Crespo, Alec Paschalis, Wei Yuan, Joaquin Mateo, Johann S. de Bono, Sara Arce-Gallego, Stephen J. Pettitt, Violeta Serra, Bora Gurel, Suzanne Carreira, Diletta Bianchini, Jane Goodall, Pasquale Rescigno, Christopher J. Lord, Alba Llop-Guevara, Ana Ferreira, Rita Pereira, Jan Rekowski, George Seed, Ines Figueiredo

المساهمون: Institut Català de la Salut, [Carreira S, Porta N, Seed G] The Institute of Cancer Research, London, UK. [Arce-Gallego S, Llop-Guevara A, Serra V] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Mateo J] The Institute of Cancer Research, London, UK. The Royal Marsden NHS Foundation Trust, London, UK. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Cancer Discovery
Scientia

مصطلحات موضوعية: 0301 basic medicine, Male, ADN - Reparació, Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms [DISEASES], Genetic Phenomena::DNA Repair [PHENOMENA AND PROCESSES], DNA Repair, DNA repair, PALB2, RAD51, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Antineoplastic Agents, Poly(ADP-ribose) Polymerase Inhibitors, Other subheadings::Other subheadings::/drug therapy [Other subheadings], fenómenos genéticos::reparación del ADN [FENÓMENOS Y PROCESOS], Germline, Medicaments antineoplàstics, Olaparib, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Medicine, Humans, business.industry, Prostatic Neoplasms, Pròstata - Càncer - Tractament, medicine.disease, 3. Good health, neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales masculinos::neoplasias de la próstata [ENFERMEDADES], 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, PARP inhibitor, Cancer research, Homologous recombination, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b5d78c938c629cb6907d0513760b356Test
https://pubmed.ncbi.nlm.nih.gov/34045297Test

المؤلفون: Johann S. de Bono, Petri Bono, John Aspegren, Sophie Postel-Vinay, Amir Snapir, Malaka Ameratunga, Irene Brana, Ruth Plummer, Timo Korjamo

المساهمون: HUS Comprehensive Cancer Center, Heikki Joensuu / Principal Investigator, Department of Oncology, Institut Català de la Salut, [Ameratunga M] The Institute of Cancer Research and Royal Marsden, London, UK. Monash University, Melbourne, Australia. [Braña I] Vall d’Hebron Institut of Oncology (VHIO), Barcelona, Spain. [Bono P] Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. University of Helsinki, Helsinki, Finland. Terveystalo Finland and University of Helsinki, Helsinki, Finland. [Postel-Vinay S] Drug Development Department, DITEP, Gustave Roussy, Villejuif, France. [Plummer R] Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. [Aspegren J] Orion Corporation Orion Pharma, Espoo, Finland, Vall d'Hebron Barcelona Hospital Campus

المصدر: British Journal of Cancer
Scientia

مصطلحات موضوعية: Male, Cancer Research, Lung Neoplasms, Pyridines, Administration, Oral, Càncer - Quimioteràpia, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Gastroenterology, RECOMMENDATIONS, Medicaments antineoplàstics, 0302 clinical medicine, Breast cancer, Carcinoma, Non-Small-Cell Lung, Neoplasms, LYMPHOMA, Medicine, Melanoma, Oxazoles, Fatigue, Ovarian Neoplasms, 0303 health sciences, Prostate cancer, Pharmaceutics, Lymphoma, Non-Hodgkin, Sarcoma, Middle Aged, CANCER, 3. Good health, Prostatic Neoplasms, Castration-Resistant, Editorial, Oncology, 030220 oncology & carcinogenesis, Toxicity, Vomiting, Quinolines, Female, Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [CHEMICALS AND DRUGS], medicine.symptom, Adult, Blood Platelets, medicine.medical_specialty, Adolescent, Maximum Tolerated Dose, Nausea, 3122 Cancers, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Biological Availability, Antineoplastic Agents, Breast Neoplasms, Drug development, Anorexia, Article, Drug Administration Schedule, neoplasias [ENFERMEDADES], BET inhibitor, 03 medical and health sciences, Young Adult, Pharmacokinetics, Protein Domains, Internal medicine, DOSE-ESCALATION, Humans, 030304 developmental biology, Aged, business.industry, acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos [COMPUESTOS QUÍMICOS Y DROGAS], Proteins, Small Cell Lung Carcinoma, P-TEFB, Discontinuation, Neoplasms [DISEASES], Clinical trial, business, BROMODOMAIN INHIBITION

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2306c38aafebd4ec618c7b751cd3d071Test
https://pubmed.ncbi.nlm.nih.gov/32989227Test

المؤلفون: Palomeras, S., Díaz-Lagares, Angel, Viñas, G., Setien, F., Ferreira, H.J., Oliveras, G., Crujeiras, A.B., Hernández, A., Lum, D.H., Welm, A.L., Esteller, M., Puig, T., Universitat Autònoma de Barcelona

المصدر: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Breast Cancer Research : BCR
Dipòsit Digital de la UB
Universidad de Barcelona
Breast Cancer Research, Vol 21, Iss 1, Pp 1-16 (2019)
Breast Cancer Research, 2019, vol. 21, art.núm. 79
Articles publicats (D-CM)
DUGiDocs – Universitat de Girona
instname

مصطلحات موضوعية: Receptor, ErbB-2, Cancer -- Treatment, Epigenesis, Genetic, Medicaments antineoplàstics, Epigènesi, 0302 clinical medicine, Trastuzumab, Transforming Growth Factor beta, Antineoplastic agents, Breast -- Cancer, Promoter Regions, Genetic, skin and connective tissue diseases, Trastuzumab resistance, Epigenomics, Extracellular Matrix Proteins, DNA methylation, Enzyme inhibitors, Methylation, Extracellular matrix, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Matriu extracel·lular, 3. Good health, Gene Expression Regulation, Neoplastic, 030220 oncology & carcinogenesis, Female, Càncer -- Tractament, Growth factors, medicine.drug, Research Article, Farmacologia, Antineoplastic Agents, Breast Neoplasms, Biology, lcsh:RC254-282, Factors de creixement, 03 medical and health sciences, Breast cancer, Cell Line, Tumor, medicine, Genetics, Gene silencing, Humans, Gene Silencing, neoplasms, Neoplasm Staging, Resistència als medicaments, Pharmacology, Gene Expression Profiling, Cancer, Sequence Analysis, DNA, HER2+ breast cancer, medicine.disease, Inhibidors enzimàtics, Drug Resistance, Neoplasm, Drug resistance, Cancer research, Mama -- Càncer, CpG Islands, Neoplasm Grading, Genètica, TGFBI, Epigenesis

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b2bcb771acd4e705193bd3d20537cfeTest
https://ddd.uab.cat/record/236896Test

المؤلفون: Hana Algül, Anke Reinacher-Schick, Katia Schlienger, David McGuinness, Teresa Macarulla, Eric Van Cutsem, Talia Golan, Giampaolo Tortora, Gershon Y. Locker, Pascal Hammel, Daniel Hochhauser, Karen Y. Cui, Do Youn Oh, Michael J. Hall, Michele Reni, Hedy L. Kindler, Joon Oh Park, Dirk Arnold, Eileen M. O'Reilly

المساهمون: [Golan T] Oncology Institute, Sheba Medical Center, Tel Aviv, Israel. Tel Aviv University, Tel Aviv, Israel. [Hammel P] Hôpital Beaujon (Assistance Publique–Hopitaux de Paris), Clichy, France. University Paris VII, Paris, France. [Reni M] IRCCS Ospedale San Raffaele Scientific Institute, Milan, Italy. [Van Cutsem E] University Hospitals Gasthuisberg and KU Leuven, Leuven, Belgium. [Macarulla T ] Hospital Universitari Vall d’Hebron , Barcelona, Spain. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Hall MJ] Fox Chase Cancer Center, Philadelphia, USA., Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Golan, T, Hammel, P, Reni, M, Van Cutsem, E, Macarulla, T, Hall, Mj, Park, Jo, Hochhauser, D, Arnold, D, Oh, Dy, Reinacher-Schick, A, Tortora, G, Algül, H, O'Reilly, Em, Mcguinness, D, Cui, Ky, Schlienger, K, Locker, Gy, Kindler, Hl

المصدر: Scientia
Recercat. Dipósit de la Recerca de Catalunya
instname
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)

مصطلحات موضوعية: Male, endocrine system diseases, FOLFIRINOX, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Germline, Piperazines, Medicaments antineoplàstics, chemistry.chemical_compound, 0302 clinical medicine, 80 and over, 030212 general & internal medicine, Neoplasm Metastasis, skin and connective tissue diseases, Polymerase, biology, General Medicine, Middle Aged, Adenocarcinoma, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Double-Blind Method, Female, Humans, Pancreatic Neoplasms, Phthalazines, Progression-Free Survival, Genes, BRCA1, Genes, BRCA2, Germ-Line Mutation, Maintenance Chemotherapy, 3. Good health, Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [CHEMICALS AND DRUGS], medicine.drug, fenómenos genéticos::variación genética::mutación::mutación de la línea germinal [FENÓMENOS Y PROCESOS], Digestive System Diseases::Digestive System Neoplasms::Digestive System Diseases::Pancreatic Neoplasms [DISEASES], Genetic Phenomena::Genetic Variation::Mutation::Germ-Line Mutation [PHENOMENA AND PROCESSES], Olaparib, 03 medical and health sciences, Germline mutation, medicine, Progression-free survival, Gens del càncer, Settore MED/06 - ONCOLOGIA MEDICA, business.industry, Pàncrees - Tumors, acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos [COMPUESTOS QUÍMICOS Y DROGAS], medicine.disease, BRCA1, BRCA2, Gemcitabine, chemistry, Genes, enfermedades del sistema digestivo::neoplasias del sistema digestivo::enfermedades del sistema digestivo::neoplasias pancreáticas [ENFERMEDADES], biology.protein, Cancer research, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b64d853e6f7d1fdbed009f2e8888459dTest
http://hdl.handle.net/10807/155162Test

المؤلفون: WEINKOVE, Robert, PRISTUPA, Alexander, KASYCH, Muzhdaba, YAGCI, Munci, MARCO, Jose Antonio Garcia, Vural, Filiz, Kaynar, Leylagül, BURGER, J. A., ROBAK, T., TEDESCHI, A., Barr, P. M., Owen, C., GHIA, P., Bairey, O., HILLMEN, P., BARTLETT, N. L., LI, J., SIMPSON, D., GROSICKI, S., HAMBLIN, Michael, ATKINS, James, BARRIENTOS, Jaqueline, DUNCOMBE, Andrew, GASIC, Slavisa, HOU, Jing-Zhou, KINGSLEY, Edwin, SHADMAN, Mazyar, BADOUX, Xavier, GILL, Devinder, OPAT, Stephen, BRON, Dominique, VAN DEN NESTE, Eric, JING, Hongmei, ZHU, Jun, VANDENBERGHE, Elisabeth, TADMOR, Tamar, CORTELEZZI, Agostino, GANLY, Peter, PLUTA, Andrzej, DEVEREUX, S., MCCARTHY, H., COUTRE, S., QUACH, H., GAIDANO, G., MASLYAK, Z., STEVENS, D. A., JANSSENS, A., OFFNER, F., MAYER, J., O'DWYER, M., HELLMANN, A., Schuh, A., SIDDIQI, T., POLLIACK, A., TAM, C. S., SURI, D., CHENG, M., CLOW, F., STYLES, L., JAMES, D. F., KIPPS, T. J., TIRUMALI, Nagendra, QUACKENBUSH, Robert, FEGAN, Christopher, KEATING, Michael, JEN, Jie, JINDRA, Pavel, SIMKOVIC, Martin, BRAESTER, Andrei, RUCHLEMER, Rosa, FOA, Roberto, SEMENZATO, Gianpietro, HAWKINS, Timothy, ATANASIO, Carolina Moreno, Demirkan, Fatih, PYLYPENKO, Halyna, FOX, Christopher, THIRMAN, Michael, CAMPBELL, Philip, COUGHLIN, Paul, HARRUP, Rosemary, KUSS, Bryone, TURNER, Paul, WU, Ka Lung, LARRATT, Loree, FINEMAN, Riva, MARASCA, Roberto, ZINZANI, Pier Luigi, CORBETT, Gillian, ABRISQUETA, Pau, DELGADO, Julio, GONZALEZ-BARCA, Eva, DE OTEYZA, Jaime Perez, ARSLAND, Onder, KAPLAN, Polina, OLIYNYK, Hanna

المساهمون: Burger, Jan A, Tedeschi, Alessandra, Barr, Paul M, Robak, Tadeusz, Owen, Carolyn, Ghia, Paolo, Bairey, Osnat, Hillmen, Peter, Bartlett, Nancy L, Li, Jianyong, Simpson, David, Grosicki, Sebastian, Devereux, Stephen, Mccarthy, Helen, Coutre, Steven, Quach, Hang, Gaidano, Gianluca, Maslyak, Zvenyslava, Stevens, Don A, Janssens, Ann, Offner, Fritz, Mayer, Jiří, O'Dwyer, Michael, Hellmann, Andrzej, Schuh, Anna, Siddiqi, Tanya, Polliack, Aaron, Tam, Constantine S, Suri, Deepali, Cheng, Mei, Clow, Fong, Styles, Lori, James, Danelle F, Kipps, Thomas J, M.D., Ph.D., for the RESONATE-2 Investigators [.., Pier Luigi Zinzani, Antonietta Tedeschi, ], Burger, Ja, Tedeschi, A, Barr, Pm, Robak, T, Owen, C, Ghia, P, Bairey, O, Hillmen, P, Bartlett, Nl, Li, J, Simpson, D, Grosicki, S, Devereux, S, Mccarthy, H, Coutre, S, Quach, H, Gaidano, G, Maslyak, Z, Stevens, Da, Janssens, A, Offner, F, Mayer, J, O'Dwyer, M, Hellmann, A, Schuh, A, Siddiqi, T, Polliack, A, Tam, C, Suri, D, Cheng, M, Clow, F, Styles, L, James, Df, Kipps, Tj, for the RESONATE-2, Investigators

المصدر: Dipòsit Digital de la UB
Universidad de Barcelona
The New England journal of medicine, vol 373, iss 25

مصطلحات موضوعية: Male, pci-32765, previously untreated patients, Lymphoma, Gastroenterology, Medical and Health Sciences, Medicaments antineoplàstics, Antineoplastic Agent, chemistry.chemical_compound, 0302 clinical medicine, chlorambucil, Piperidines, Obinutuzumab, immune system diseases, hemic and lymphatic diseases, Antineoplastic agents, Chronic, Fatigue, Cancer, cll, 0303 health sciences, Leukemia, Medicine (all), Hazard ratio, tyrosine kinase, Leucèmia, General Medicine, Hematology, Duvelisib, Lymphocytic, 3. Good health, Fludarabine, Aged, Antineoplastic Agents, Chlorambucil, Diarrhea, Disease-Free Survival, Female, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Neutropenia, Pyrazoles, Pyrimidines, Survival Analysis, 030220 oncology & carcinogenesis, Ibrutinib, 6.1 Pharmaceuticals, RESONATE-2 Investigators, Acalabrutinib, medicine.drug, Human, medicine.medical_specialty, Cèl·lules B, Clinical Trials and Supportive Activities, open-label, 03 medical and health sciences, Rare Diseases, Clinical Research, Internal medicine, General & Internal Medicine, medicine, cancer, Survival rate, 030304 developmental biology, B cells, business.industry, Adenine, B-Cell, fludarabine, Evaluation of treatments and therapeutic interventions, phase-3 trial, Pirimidines, Orphan Drug, chemistry, Pyrimidine, Immunology, Pyrazole, cyclophosphamide, business

وصف الملف: application/pdf; STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3304e4a94b8fb634a7251e188be4a3beTest
https://avesis.erciyes.edu.tr/publication/details/c667ddad-1b04-4167-a0a8-6225d2d685db/oaiTest

المؤلفون: Robak, Tadeusz, Huang, Huiqiang, Jin, Jie, Zhu, Jun, Liu, Ting, Samoilova, Olga, Pylypenko, Halyna, Verhoef, Gregor, Siritanaratkul, Noppadol, Osmanov, Evgenii, Alexeeva, Julia, Pereira, Juliana, Drach, Johannes, Mayer, Jiří, Hong, Xiaonan, Okamoto, Rumiko, Pei, Lixia, Rooney, Brendan, Van de Velde, Helgi, Cavalli, Franco, González Barca, Eva, LYM-3002 Investigators

المصدر: Dipòsit Digital de la UB
Universidad de Barcelona

مصطلحات موضوعية: Male, Oncology, Limfomes, Kaplan-Meier Estimate, Lymphoma, Mantle-Cell, Medicaments antineoplàstics, Bortezomib, Antibodies, Monoclonal, Murine-Derived, 0302 clinical medicine, immune system diseases, Prednisone, hemic and lymphatic diseases, Ús terapèutic, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic agents, Infusions, Intravenous, Aged, 80 and over, 0303 health sciences, General Medicine, Middle Aged, Boronic Acids, 3. Good health, Vincristine, Pyrazines, 030220 oncology & carcinogenesis, Female, Rituximab, Lymphomas, medicine.drug, Adult, medicine.medical_specialty, Disease-Free Survival, 03 medical and health sciences, Internal medicine, medicine, Humans, Cyclophosphamide, Aged, 030304 developmental biology, business.industry, Therapeutic use, medicine.disease, Hematologic Diseases, Surgery, Transplantation, Regimen, Doxorubicin, Proteasome inhibitor, Mantle cell lymphoma, business, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afee560eb15f7111bf844d3bc47adb1bTest
http://hdl.handle.net/2445/178533Test

المؤلفون: Magali Contensin, Benjamin Roux, Fabrice Daian, Daniele Passarella, Alessandro Furlan, Flavio Maina, Joan Bosch, Jean-François Guillemot, Fabienne Lamballe, Oreste Piccolo, Sylvie Richelme, Nathalie Issaly, Filippo Conti, Rosanna Dono

المساهمون: Laboratoire de Physique des Lasers, Atomes et Molécules - UMR 8523 (PhLAM), Université de Lille-Centre National de la Recherche Scientifique (CNRS), Institut de Biologie du Développement de Marseille (IBDM), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Centre d'Immunologie de Marseille - Luminy (CIML), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Universitat de Barcelona (UB), Università degli Studi di Milano [Milano] (UNIMI), Studio di Consulenza Scientifica, INCa (Institut National du Cancer), ARC (Association pour la recherche contre le cancer), FRM (Fondation pour la recherche médicale), FdF (Fondation de France), Fondation Bettencourt-Schueller, Marie Curie Host Fellowship for the Transfer of Knowledge (MTKD-CT-2004-509804), Protisvalor, Valorpaca, and Oséo, Universitat de Barcelona, Università degli Studi di Milano = University of Milan (UNIMI)

المصدر: Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE
PLoS ONE, Public Library of Science, 2012, 7 (10), pp.e46738. ⟨10.1371/journal.pone.0046738⟩
Recercat. Dipósit de la Recerca de Catalunya
instname
PLoS ONE, Vol 7, Iss 10, p e46738 (2012)
PLoS ONE, 2012, 7 (10), pp.e46738. ⟨10.1371/journal.pone.0046738⟩

مصطلحات موضوعية: Drug targeting, Carcinogenesis, MESH: Cell Cycle, Cell Cycle Proteins, Drug action, [CHIM.THER]Chemical Sciences/Medicinal Chemistry, Pharmacology, Biochemistry, Desenvolupament de medicaments, Mice, 0302 clinical medicine, MESH: Molecular Targeted Therapy, Tyrosine Kinase Signaling Cascade, Antineoplastic agents, MESH: Animals, MESH: Receptors, Platelet-Derived Growth Factor, Membrane Receptor Signaling, Receptors, Platelet-Derived Growth Factor, Molecular Targeted Therapy, lcsh:Science, Càncer, MESH: Protein Interaction Maps, Cancer, 0303 health sciences, Cell Cycle, 3. Good health, Cell Transformation, Neoplastic, Dianes farmacològiques, MESH: Cell Survival, Oncology, Drug screening, 030220 oncology & carcinogenesis, Cancer treatment, Medicine, Oncology Agents, MESH: Protein Transport, MESH: Xenograft Model Antitumor Assays, Bioinformatics, Antineoplastic Agents, Drug development, 03 medical and health sciences, MESH: Cell Cycle Proteins, MESH: Mice, Nude, Humans, MESH: Benzothiazoles, Biology, MESH: Mutation, Missense, MESH: Humans, MESH: Phosphorylation, MESH: Transcriptome, lcsh:R, Proteins, medicine.disease, Transmembrane Proteins, Thiazoles, Cancer cell, MESH: Antineoplastic Agents, lcsh:Q, Gene expression, MESH: Signal Transduction, Cancer cells, lcsh:Medicine, MESH: Proto-Oncogene Proteins c-met, medicine.disease_cause, Medicaments antineoplàstics, Molecular Cell Biology, Basic Cancer Research, Protein Interaction Maps, Phosphorylation, Multidisciplinary, Protein Kinase Signaling Cascade, Cell Death, Retinoblastoma, Proto-Oncogene Proteins c-met, Cell cycle, Signaling Cascades, Protein Transport, Cèl·lules canceroses, medicine.symptom, Signal transduction, Metabolic Networks and Pathways, Research Article, Signal Transduction, MESH: Cell Line, Tumor, Cell Survival, Mutation, Missense, Mice, Nude, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, Oncogenic signaling, Tiazoles, MESH: Cell Proliferation, Growth Factors, Cell Line, Tumor, medicine, Animals, Benzothiazoles, MESH: Mice, Cell Proliferation, 030304 developmental biology, Toxicity, Cell growth, Xenograft Model Antitumor Assays, Expressió gènica, Cell cycle and cell division, Mechanism of action, MESH: Metabolic Networks and Pathways, MESH: Cell Transformation, Neoplastic, MESH: Protein Processing, Post-Translational, Cancer research, Transcriptome, Protein Processing, Post-Translational

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fadae469ddb323a091db6b7da276b7b8Test
http://hdl.handle.net/2445/61564Test

المؤلفون: Marc Martí, Josep Farrera-Sinfreu, Carmen Cuevas, Pilar Calvo, Andrés Francesch, Fernando Albericio, Rosa Aligué, Miriam Royo, Daniel Pla, Daniel Pulido, Mercedes Álvarez

المساهمون: Laboratoire Hétérochimie Fondamentale et Appliquée (LHFA), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Institut de Chimie de Toulouse (ICT-FR 2599), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD), Pharma Mar SA, Sociedad Unipersonal, Madrid, Pharma Mar SA, Sociedad Unipersonal, Inst Res Biomed, University of Barcelona, Universitat de Barcelona

المصدر: Bioconjugate Chemistry
Bioconjugate Chemistry, American Chemical Society, 2009, 20 (6), pp.1112-1121. ⟨10.1021/bc800504t⟩
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname

مصطلحات موضوعية: Productes naturals marins, Nuclear Localization Signals, Pharmaceutical Science, Peptide, 01 natural sciences, Polyethylene Glycols, Medicaments antineoplàstics, chemistry.chemical_compound, Coumarins, Antineoplastic agents, Internalization, ComputingMilieux_MISCELLANEOUS, media_common, chemistry.chemical_classification, Compostos heterocíclics, 0303 health sciences, Transport biològic, 3. Good health, DNA Topoisomerases, Type I, Marine natural products, Lamellarin D, Heterocyclic compounds, Biological transport, Biotechnology, Dendrimers, Stereochemistry, media_common.quotation_subject, Green Fluorescent Proteins, Biomedical Engineering, Antineoplastic Agents, Bioengineering, Transfection, Heterocyclic Compounds, 4 or More Rings, 03 medical and health sciences, Cell Line, Tumor, Dendrimer, Humans, [CHIM]Chemical Sciences, 030304 developmental biology, Pharmacology, Isoquinoline, 010405 organic chemistry, Isoquinolina, Organic Chemistry, Biological Transport, Isoquinolines, 0104 chemical sciences, chemistry, Cell culture, Biophysics, Ethylene glycol, Nuclear localization sequence, Conjugate

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97949c82fb862c642251e92cfc4853e0Test
https://hal.archives-ouvertes.fr/hal-02364292Test

المؤلفون: Marta Altuna, Daniel Pla, Miroslav Šíša, Fernando Albericio, Mercedes Álvarez, Carmen Cuevas, Andrés Francesch

المساهمون: Laboratoire Hétérochimie Fondamentale et Appliquée (LHFA), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Institut de Chimie de Toulouse (ICT-FR 2599), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD), Inst Res Biomed, University of Barcelona, Universitat de Barcelona

المصدر: Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, American Chemical Society, 2009, 52 (20), pp.6217-6223. ⟨10.1021/jm900544z⟩
Recercat. Dipósit de la Recerca de Catalunya
instname

مصطلحات موضوعية: Marine metabolites, Stereochemistry, Imine, chemistry.chemical_element, Antineoplastic Agents, 010402 general chemistry, 01 natural sciences, Metabòlits marins, Indole Alkaloids, Medicaments antineoplàstics, Síntesi de fàrmacs, Inhibitory Concentration 50, Structure-Activity Relationship, chemistry.chemical_compound, Drug synthesis, Alkaloids, Cell Line, Tumor, Drug Discovery, Antineoplastic agents, Alcaloides, [CHIM]Chemical Sciences, Humans, Cytotoxicity, ComputingMilieux_MISCELLANEOUS, Cell Proliferation, Indole test, Bromine, 010405 organic chemistry, Total synthesis, In vitro, 3. Good health, 0104 chemical sciences, Human tumor, chemistry, Cell culture, Molecular Medicine, Drug Screening Assays, Antitumor

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b0ce42c7ad110e19fb4b0ae2a6d928dTest
http://hdl.handle.net/2445/56023Test

المؤلفون: Mercedes Álvarez, Daniel Pla, Fernando Albericio

المساهمون: Laboratoire Hétérochimie Fondamentale et Appliquée (LHFA), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Institut de Chimie de Toulouse (ICT-FR 2599), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD), Universitat de Barcelona

المصدر: Anti-Cancer Agents in Medicinal Chemistry
Anti-Cancer Agents in Medicinal Chemistry, Bentham Science Publishers, 2008, 8 (7), pp.746-760. ⟨10.2174/187152008785914789⟩
Dipòsit Digital de la UB
Universidad de Barcelona
Scopus-Elsevier
ResearcherID
Recercat. Dipósit de la Recerca de Catalunya
instname

مصطلحات موضوعية: Cancer Research, Productes naturals marins, Cell Survival, Antineoplastic Agents, HIV Integrase, Pharmacology, 010402 general chemistry, DNA, Mitochondrial, Heterocyclic Compounds, 4 or More Rings, 01 natural sciences, Medicaments antineoplàstics, Inhibitory Concentration 50, Structure-Activity Relationship, chemistry.chemical_compound, Alkaloids, Coumarins, Cell Line, Tumor, Antineoplastic agents, Alcaloides, Animals, Humans, Structure–activity relationship, [CHIM]Chemical Sciences, HIV Integrase Inhibitors, Urochordata, ComputingMilieux_MISCELLANEOUS, chemistry.chemical_classification, Compostos heterocíclics, Molecular Structure, biology, 010405 organic chemistry, Topoisomerase, Total synthesis, Mitochondria, 0104 chemical sciences, 3. Good health, Integrase, Enzyme, chemistry, Mollusca, Cell culture, Marine natural products, Lamellarin D, biology.protein, Molecular Medicine, Efflux, Heterocyclic compounds, Topoisomerase I Inhibitors

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f32e2dddf55783571634dcaf1f37103cTest
https://hal.archives-ouvertes.fr/hal-02364306Test